Global Rapid Tests Kits Market By Product (Over-the-Counter (OTC), and Professional), By Application (Infectious Disease (HPV Rapid Tests Kits, Hepatitis Rapid Tests Kits, Influenza Rapid Tests Kits, Malaria Rapid Tests Kits, HIV Rapid Tests Kits, COVID – 19, and Other Infectious Disease Rapid Tests Kits), Cardiology, Oncology, Pregnancy & Fertility, Toxicology, Glucose Monitoring, and Others), By End-user (Hospitals & Clinics, Diagnostic Laboratories, Home Care, and Others), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
Rapid Tests Kits Market Outlook
The Global Rapid Tests Kits Market was valued at USD xx million in 2020 and is projected to reach USD xx million by 2028, expanding at a CAGR of xx% during the forecast period. Food goods are tested for infections, meat speciation, GMOs, allergies, pesticides, mycotoxins, heavy metals, and other contaminants using Rapid Tests Kits. The market for Rapid Tests Kits is being driven by the increased demand for both faster and quantitative test results to assure food safety. Market companies are increasing their global footprint and service offerings in response to these new prospects.
Rapid Tests Kits, also known as rapid diagnostic tests (RDTs), are easy to use and typically provide results within 20 minutes. These tests are useful for conducting preliminary screening. In particular, Rapid Tests Kits are useful in settings where resources are limited. A rapid antigen test can be administered for individuals with or without COVID-19 symptoms.
These tests include the collection nose and throat secretions using nasopharyngeal swab and then examining them for protein fragments specific to the COVID-19 virus. Rapid antigen tests are most reliable when people are in the early stages of COVID-19, when the viral load is highest in the throat and nasal passages. The government has shipped millions of rapid COVID tests to nursing homes, schools, and other facilities. Rapid COVID tests are available at other point-of-care facilities, such as pharmacies.
COVID-19 did not hamper the Rapid Tests Kits market, as these tests are widely used in the healthcare sector. Manufacturers in the market were focused on investing in R&D activities, which drove the market during the pandemic. Growing R&D activities increased for COVID-19 pandemic, which is expected to fuel the market.
Researchers in several countries are working on creating effective and affordable Rapid Tests Kits to detect COVID-19 in people. These developments are expected to significantly propel the healthcare sector. Many major players and some startups from various countries have introduced COVID-19 diagnostic kits. This, in turn, is expected to propel the global Rapid Tests Kits market during the forecast period.
Scope of Rapid Tests Kits Market Report
The report on the Global Rapid Tests Kits market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Global Rapid Tests Kits Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast |
Base Year |
2020 |
Historic Data |
2018–2019 |
Forecast Period |
2021–2028 |
Segmentation |
By Product (Over-the-Counter (OTC), and Professional), By Application (Infectious Disease (HPV Rapid Tests Kits, Hepatitis Rapid Tests Kits, Influenza Rapid Tests Kits, Malaria Rapid Tests Kits, HIV Rapid Tests Kits, COVID – 19, and Other Infectious Disease Rapid Tests Kits), Cardiology, Oncology, Pregnancy & Fertility, Toxicology, Glucose Monitoring, and Others), By End-user (Hospitals & Clinics, Diagnostic Laboratories, Home Care, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered |
Abbott, BD, Bio-Rad Laboratories, Inc., Cepheid, Meridian Bioscience, Inc., OraSure Technologies, Quidel Corporation, F. Hoffmann-La Roche Ltd. , VedaLab, Atlas Medical GmbH, Abingdon Health, Vitrosens Biotechnology, Advin Health care, Rapikit, and MP Biomedicals. |
Rapid Tests Kits Market Dynamics
Increasing Prevalence of Infectious Diseases
A rapid test is widely used in diagnosing infectious diseases such as HIV, malaria, influenza, flu, HPV, hepatitis, and strep throat. Rapid Tests Kits are widely adopted for preliminary screening and increasing incidences of infections such as hepatitis, HIV, and HPV, thus propelling the global Rapid Tests Kits market during the forecast period. Lateral-flow and immunochromatographic Rapid Tests Kits are used to detect certain infections, as these are point-of-care (POC) tests. Increasing incidences of infectious diseases is projected to fuel the Rapid Tests Kits market during the forecast period.
Sudden Outbreak & Spread of COVID-19
Several people were infected by the COVID-19 virus, which significantly changed the scenario of healthcare infrastructure across the world. Governments, healthcare companies, and institutions have developed multiple COVID-19 rapid test kits. For instance, in 2020, Cipla Inc. partnered with Premier Medical Corporation Private Limited for the commercialization of the rapid antigen detection test kits in India, which detects the COVID-19 virus within 15 to 20 minutes. Additionally, governments around the world, such as the UK Government developed nationwide COVID-19 testing program with the help of rapid test kits.
Growing Preference for Home Healthcare
Governments have imposed strict lockdown and restrictions on traveling and movement of goods & services due to the spread the COVID-19 pandemic worldwide. The fear of contracting and spreading the virus made people across the globe adopt home-based healthcare treatment. People avoided visiting healthcare facilities such as diagnostic centers and hospitals & clinics. They preferred using rapid test kits at home for pregnancy/fertility testing and glucose monitoring. People started using rapid antibody and antigen kits for COVID-19 testing at homes, which in turn, propelled the market.
Rising Geriatric Population
According to the United Nation Population Division of the Department of Economic and Social Affairs, the number of people aged 65 years or above was 703 million in 2019 and this number is anticipated to rise to 120% between 2019 and 2050. This number is expected to reach 1548.9 million by 2050. Growing geriatric population, exposed to various kinds of non-communicable and communicable diseases, is anticipated to drive the market in the coming years. Rapid test kits are used for glucose monitoring, thus propelling the market during the forecast period.
Increasing Healthcare Expenditure
The expenditure on healthcare is growing across different countries, which is projected to improve the existing medical and healthcare devices market. This is anticipated to fuel the market by 2028. According to the WHO, the global spending on healthcare was around USD 8.3 trillion in 2018, which was about 10% of the global economy.
This spending is projected to increase significantly in the coming years. The demand for healthcare services has increased due to the sudden outbreak and spread of the COVID-19 virus. This expenditure is expected to increase in the coming years due to the rising demand for other healthcare services and medical devices, thereby creating opportunities in the global rapid test kit market.
Rapid Tests Kits Market Segmental Outlook
The Global Rapid Tests Kits market is segmented on the basis of Product, Application, End-user, and regions.
Based on products, the Rapid Tests Kits market is bifurcated into Over-the-Counter (OTC), and Professional. At present, the Over-the-Counter (OTC) rapid test product segment contributes for the highest market share among all products, and is anticipated to continue to remain dominant during the forecast period majorly due to the rise in incidence of diabetes. Also factors such as rise in preliminary screening procedures in hospitals and surge in adoption of Rapid Tests Kits in the developing regions of Asia and Africa drive the growth of the professional rapid test products market.
Based on applications, the global Rapid Tests Kits market is segmented into infectious disease, cardiology, oncology, pregnancy & fertility, toxicology, glucose monitoring, and others. The infectious disease segment is further categorized into HPV Rapid Tests Kits, hepatitis Rapid Tests Kits, influenza Rapid Tests Kits, malaria Rapid Tests Kits, HIV Rapid Tests Kits, COVID-19 Rapid Tests Kits, and other infectious disease Rapid Tests Kits.
During the projected period, the infectious disease rapid testing market is expected to develop at the fastest rate. The global infectious disease quick tests market is growing due to an increase in the usage of Rapid Tests Kits for preliminary screening and an increase in the incidence of illnesses such as HIV, HPV, hepatitis, and others.
Glucose monitoring is the greatest revenue contributor at the moment, and it is expected to continue to dominate the market over the projection period. The market's growth is fueled by the easy availability of low-cost products, a large diabetes population, and an increase in the use of glucose monitoring fast testing devices among the general population.
Based on end-users, the global Rapid Tests Kits market is classified as hospitals & clinics, diagnostic, laboratories, homecare, and others. The diagnostic segment is estimated to holds a significant market share during the forecast period, as these center conduct various types of test such as COVID-19, HIV, glucose monitoring, and HPV.
The homecare segment is expected to account for a considerable share of the rapid test market in the coming years due to the spread of Coronavirus pandemic and rising awareness regarding the at-home test kits such as glucose monitoring. The others segment is expected to hold a substantial market share and is anticipated to grow during the forecast period.
Rapid Tests Kits Market Regional Outlook
Based on regions, the global Rapid Tests Kits market is fragmented into North America, Europe, Latin America, and Middle East & Africa. The market in North America is projected to expand at a significant CAGR during the forecast period, owing to increasing use of rapid antigen test kits at home. The US is expected to account for a significant share of the market in the region during the forecast period. In the US, allergies are the sixth leading cause of chronic illness.
To help ensure that the people in the country have COVID-19 tests on hand, if a need arises, the Biden Administration has purchased one billion at-home, rapid COVID-19 tests to give to provide the citizens for free.
Asia-Pacific presents lucrative opportunities for the players operating in the Rapid Tests Kits market, on account of its high population base, increase in disposable incomes, and growth in awareness about advance Rapid Tests Kits. Furthermore, the fast test market is growing due to an increase in the incidence of various diseases and an increase in R&D spending in developing nations such as India, China, and Brazil.
Key Benefits for Industry Participants & Stakeholders
- In-depth Analysis of the Global Rapid Tests Kits Market
- Historical, Current, and Projected Market Size in terms of Value and Volume
- Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
- Industry Drivers, Restraints, and Opportunities Covered in the Study
- Recent Industry Trends and Developments
- Competitive Landscape & Strategies of Key Players
- Neutral Perspective on Global Rapid Tests Kits Market Performance
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Rapid Tests Kits Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Rapid Tests Kits Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Rapid Tests Kits Market- Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Rapid Tests Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Rapid Tests Kits Market Size & Forecast, 2018-2028
4.5.1 Rapid Tests Kits Market Size and Y-o-Y Growth
4.5.2 Rapid Tests Kits MarketAbsolute $ Opportunity
4.6 Environmental Threat Opportunity Profile (ETOP) Analysis
4.7 Market Entry Strategies
4.8 Current & Future Trends
4.9 PESTEL Analysis
4.10 Pipeline/Clinical Trial Analysis
4.11 Pre & Post-COVID Scenario
4.12 Technology Outlook Trends/Disruptions Impacting Customers’ Businesses
4.13 Regulation Overview
Chapter 5 Global Rapid Tests Kits Market Analysis and Forecast By Product
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities By Product
5.1.2 Basis Point Share (BPS) Analysis By Product
5.1.3 Absolute $ Opportunity Assessment By Product
5.2 Rapid Tests Kits Market Size Forecast By Product
5.2.1 Over-the-counter (OTC)
5.2.2 Professional
5.3 Market Attractiveness Analysis By Product
Chapter 6 Global Rapid Tests Kits Market Analysis and Forecast By Application
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities By Application
6.1.2 Basis Point Share (BPS) Analysis By Application
6.1.3 Absolute $ Opportunity Assessment By Application
6.2 Rapid Tests Kits Market Size Forecast By Application
6.2.1 Infectious Disease
6.2.1.1 HPV Rapid Tests
6.2.1.2 Hepatitis Rapid Tests
6.2.1.3 Influenza Rapid Tests
6.2.1.4 Malaria Rapid Tests
6.2.1.5 HIV Rapid Tests
6.2.1.6 COVID - 19
6.2.1.7 Other Infectious Disease Rapid Tests
6.2.2 Cardiology
6.2.3 Oncology
6.2.4 Pregnancy & Fertility
6.2.5 Toxicology
6.2.6 Glucose Monitoring
6.2.7 Others
6.3 Market Attractiveness Analysis By Application
Chapter 7 Global Rapid Tests Kits Market Analysis and Forecast By End-user
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities By End-user
7.1.2 Basis Point Share (BPS) Analysis By End-user
7.1.3 Absolute $ Opportunity Assessment By End-user
7.2 Rapid Tests Kits Market Size Forecast By End-user
7.2.1 Hospitals & clinics
7.2.2 Diagnostic laboratories
7.2.3 Home care
7.2.4 Others
7.3 Market Attractiveness Analysis By End-user
Chapter 8 Global Rapid Tests Kits Market Analysis and Forecast by Region
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Region
8.1.2 Basis Point Share (BPS) Analysis by Region
8.1.3 Absolute $ Opportunity Assessment by Region
8.2 Rapid Tests Kits Market Size Forecast by Region
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa (MEA)
8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
9.1 Introduction
9.2 Current & Future Impact Analysis
9.3 Economic Impact Analysis
9.4 Government Policies
9.5 Investment Scenario
Chapter 10 North America Rapid Tests Kits Analysis and Forecast
10.1 Introduction
10.2 North America Rapid Tests Kits Market Size Forecast by Country
10.2.1 U.S.
10.2.2 Canada
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 North America Rapid Tests Kits Market Size Forecast By Product
10.6.1 Over-the-counter (OTC)
10.6.2 Professional
10.7 Basis Point Share (BPS) Analysis By Product
10.8 Absolute $ Opportunity Assessment By Product
10.9 Market Attractiveness Analysis By Product
10.10 North America Rapid Tests Kits Market Size Forecast By Application
10.10.1 Infectious Disease
10.10.1.1 HPV Rapid Tests
10.10.1.2 Hepatitis Rapid Tests
10.10.1.3 Influenza Rapid Tests
10.10.1.4 Malaria Rapid Tests
10.10.1.5 HIV Rapid Tests
10.10.1.6 COVID - 19
10.10.1.7 Other Infectious Disease Rapid Tests
10.10.2 Cardiology
10.10.3 Oncology
10.10.4 Pregnancy & Fertility
10.10.5 Toxicology
10.10.6 Glucose Monitoring
10.10.7 Others
10.11 Basis Point Share (BPS) Analysis By Application
10.12 Absolute $ Opportunity Assessment By Application
10.13 Market Attractiveness Analysis By Application
10.14 North America Rapid Tests Kits Market Size Forecast By End-user
10.14.1 Hospitals & clinics
10.14.2 Diagnostic laboratories
10.14.3 Home care
10.14.4 Others
10.15 Basis Point Share (BPS) Analysis By End-user
10.16 Absolute $ Opportunity Assessment By End-user
10.17 Market Attractiveness Analysis By End-user
Chapter 11 Europe Rapid Tests Kits Analysis and Forecast
11.1 Introduction
11.2 Europe Rapid Tests Kits Market Size Forecast by Country
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 U.K.
11.2.5 Spain
11.2.6 Russia
11.2.7 Rest of Europe
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Europe Rapid Tests Kits Market Size Forecast By Product
11.6.1 Over-the-counter (OTC)
11.6.2 Professional
11.7 Basis Point Share (BPS) Analysis By Product
11.8 Absolute $ Opportunity Assessment By Product
11.9 Market Attractiveness Analysis By Product
11.10 Europe Rapid Tests Kits Market Size Forecast By Application
11.10.1 Infectious Disease
11.10.1.1 HPV Rapid Tests
11.10.1.2 Hepatitis Rapid Tests
11.10.1.3 Influenza Rapid Tests
11.10.1.4 Malaria Rapid Tests
11.10.1.5 HIV Rapid Tests
11.10.1.6 COVID - 19
11.10.1.7 Other Infectious Disease Rapid Tests
11.10.2 Cardiology
11.10.3 Oncology
11.10.4 Pregnancy & Fertility
11.10.5 Toxicology
11.10.6 Glucose Monitoring
11.10.7 Others
11.11 Basis Point Share (BPS) Analysis By Application
11.12 Absolute $ Opportunity Assessment By Application
11.13 Market Attractiveness Analysis By Application
11.14 Europe Rapid Tests Kits Market Size Forecast By End-user
11.14.1 Hospitals & clinics
11.14.2 Diagnostic laboratories
11.14.3 Home care
11.14.4 Others
11.15 Basis Point Share (BPS) Analysis By End-user
11.16 Absolute $ Opportunity Assessment By End-user
11.17 Market Attractiveness Analysis By End-user
Chapter 12 Asia Pacific Rapid Tests Kits Analysis and Forecast
12.1 Introduction
12.2 Asia Pacific Rapid Tests Kits Market Size Forecast by Country
12.2.1 China
12.2.2 Japan
12.2.3 South Korea
12.2.4 India
12.2.5 Australia
12.2.6 South East Asia (SEA)
12.2.7 Rest of Asia Pacific (APAC)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Asia Pacific Rapid Tests Kits Market Size Forecast By Product
12.6.1 Over-the-counter (OTC)
12.6.2 Professional
12.7 Basis Point Share (BPS) Analysis By Product
12.8 Absolute $ Opportunity Assessment By Product
12.9 Market Attractiveness Analysis By Product
12.10 Asia Pacific Rapid Tests Kits Market Size Forecast By Application
12.10.1 Infectious Disease
12.10.1.1 HPV Rapid Tests
12.10.1.2 Hepatitis Rapid Tests
12.10.1.3 Influenza Rapid Tests
12.10.1.4 Malaria Rapid Tests
12.10.1.5 HIV Rapid Tests
12.10.1.6 COVID - 19
12.10.1.7 Other Infectious Disease Rapid Tests
12.10.2 Cardiology
12.10.3 Oncology
12.10.4 Pregnancy & Fertility
12.10.5 Toxicology
12.10.6 Glucose Monitoring
12.10.7 Others
12.11 Basis Point Share (BPS) Analysis By Application
12.12 Absolute $ Opportunity Assessment By Application
12.13 Market Attractiveness Analysis By Application
12.14 Asia Pacific Rapid Tests Kits Market Size Forecast By End-user
12.14.1 Hospitals & clinics
12.14.2 Diagnostic laboratories
12.14.3 Home care
12.14.4 Others
12.15 Basis Point Share (BPS) Analysis By End-user
12.16 Absolute $ Opportunity Assessment By End-user
12.17 Market Attractiveness Analysis By End-user
Chapter 13 Latin America Rapid Tests Kits Analysis and Forecast
13.1 Introduction
13.2 Latin America Rapid Tests Kits Market Size Forecast by Country
13.2.1 Brazil
13.2.2 Mexico
13.2.3 Rest of Latin America (LATAM)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Latin America Rapid Tests Kits Market Size Forecast By Product
13.6.1 Over-the-counter (OTC)
13.6.2 Professional
13.7 Basis Point Share (BPS) Analysis By Product
13.8 Absolute $ Opportunity Assessment By Product
13.9 Market Attractiveness Analysis By Product
13.10 Latin America Rapid Tests Kits Market Size Forecast By Application
13.10.1 Infectious Disease
13.10.1.1 HPV Rapid Tests
13.10.1.2 Hepatitis Rapid Tests
13.10.1.3 Influenza Rapid Tests
13.10.1.4 Malaria Rapid Tests
13.10.1.5 HIV Rapid Tests
13.10.1.6 COVID - 19
13.10.1.7 Other Infectious Disease Rapid Tests
13.10.2 Cardiology
13.10.3 Oncology
13.10.4 Pregnancy & Fertility
13.10.5 Toxicology
13.10.6 Glucose Monitoring
13.10.7 Others
13.11 Basis Point Share (BPS) Analysis By Application
13.12 Absolute $ Opportunity Assessment By Application
13.13 Market Attractiveness Analysis By Application
13.14 Latin America Rapid Tests Kits Market Size Forecast By End-user
13.14.1 Hospitals & clinics
13.14.2 Diagnostic laboratories
13.14.3 Home care
13.14.4 Others
13.15 Basis Point Share (BPS) Analysis By End-user
13.16 Absolute $ Opportunity Assessment By End-user
13.17 Market Attractiveness Analysis By End-user
Chapter 14 Middle East & Africa (MEA) Rapid Tests Kits Analysis and Forecast
14.1 Introduction
14.2 Middle East & Africa (MEA) Rapid Tests Kits Market Size Forecast by Country
14.2.1 Saudi Arabia
14.2.2 South Africa
14.2.3 UAE
14.2.4 Rest of Middle East & Africa (MEA)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Middle East & Africa (MEA) Rapid Tests Kits Market Size Forecast By Product
14.6.1 Over-the-counter (OTC)
14.6.2 Professional
14.7 Basis Point Share (BPS) Analysis By Product
14.8 Absolute $ Opportunity Assessment By Product
14.9 Market Attractiveness Analysis By Product
14.10 Middle East & Africa (MEA) Rapid Tests Kits Market Size Forecast By Application
14.10.1 Infectious Disease
14.10.1.1 HPV Rapid Tests
14.10.1.2 Hepatitis Rapid Tests
14.10.1.3 Influenza Rapid Tests
14.10.1.4 Malaria Rapid Tests
14.10.1.5 HIV Rapid Tests
14.10.1.6 COVID - 19
14.10.1.7 Other Infectious Disease Rapid Tests
14.10.2 Cardiology
14.10.3 Oncology
14.10.4 Pregnancy & Fertility
14.10.5 Toxicology
14.10.6 Glucose Monitoring
14.10.7 Others
14.11 Basis Point Share (BPS) Analysis By Application
14.12 Absolute $ Opportunity Assessment By Application
14.13 Market Attractiveness Analysis By Application
14.14 Middle East & Africa (MEA) Rapid Tests Kits Market Size Forecast By End-user
14.14.1 Hospitals & clinics
14.14.2 Diagnostic laboratories
14.14.3 Home care
14.14.4 Others
14.15 Basis Point Share (BPS) Analysis By End-user
14.16 Absolute $ Opportunity Assessment By End-user
14.17 Market Attractiveness Analysis By End-user
Chapter 15 Competition Landscape
15.1 Rapid Tests Market: Competitive Dashboard
15.2 Global Rapid Tests Market: Market Share Analysis, 2020
15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
15.3.1 Abbott
15.3.2 BD
15.3.3 Bio-Rad Laboratories, Inc.
15.3.4 Cepheid
15.3.5 Meridian Bioscience, Inc.
15.3.6 OraSure Technologies
15.3.7 Quidel Corporation
15.3.8 F. Hoffmann-La Roche Ltd.
15.3.9 Rapikit
15.3.10 MP Biomedicals
15.3.11 VedaLab
15.3.12 Atlas Medical GmbH
15.3.13 Abingdon Health
15.3.14 Vitrosens Biotechnology
15.3.15 Advin Health care